My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 491

    1.

    Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

    Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ.

    Diabetes. 2001 Mar;50(3):609-13.PMID: 11246881 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.

    Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, Gallwitz B.

    Diabetes. 2004 Mar;53(3):654-62.PMID: 14988249 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

    Regul Pept. 2003 Jul 15;114(2-3):115-21.PMID: 12832099 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

    Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W.

    J Clin Invest. 1993 Jan;91(1):301-7.PMID: 8423228 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.

    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

    Diabetologia. 2002 Aug;45(8):1111-9. Epub 2002 Jul 4.PMID: 12189441 [PubMed - indexed for MEDLINE]Related articles

    7.

    Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.

    Deacon CF, Wamberg S, Bie P, Hughes TE, Holst JJ.

    J Endocrinol. 2002 Feb;172(2):355-62.PMID: 11834453 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903.PMID: 14557471 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.

    Hücking K, Kostic Z, Pox C, Ritzel R, Holst JJ, Schmiegel W, Nauck MA.

    Diabet Med. 2005 Apr;22(4):470-6.PMID: 15787675 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.

    Vaag AA, Holst JJ, Vølund A, Beck-Nielsen HB.

    Eur J Endocrinol. 1996 Oct;135(4):425-32.PMID: 8921824 [PubMed - indexed for MEDLINE]Related articles

    11.

    Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.

    Vilsbøll T, Agersø H, Krarup T, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jan;88(1):220-4.PMID: 12519856 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.

    Damci T, Yalin S, Balci H, Osar Z, Korugan U, Ozyazar M, Ilkova H.

    Diabetes Care. 2004 May;27(5):1077-80.PMID: 15111524 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects.

    Frid AH, Nilsson M, Holst JJ, Björck IM.

    Am J Clin Nutr. 2005 Jul;82(1):69-75.PMID: 16002802 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.

    Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ.

    Regul Pept. 2004 Nov 15;122(3):209-17.PMID: 15491793 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.

    Lee A, Patrick P, Wishart J, Horowitz M, Morley JE.

    Diabetes Obes Metab. 2002 Sep;4(5):329-35.PMID: 12190996 [PubMed - indexed for MEDLINE]Related articles

    16.

    Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

    Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3717-23.PMID: 11502801 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes.

    Lugari R, Dei Cas A, Ugolotti D, Finardi L, Barilli AL, Ognibene C, Luciani A, Zandomeneghi R, Gnudi A.

    Horm Metab Res. 2002 Mar;34(3):150-4.PMID: 11972305 [PubMed - indexed for MEDLINE]Related articles

    18.

    Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.

    Meier JJ, Kemmeries G, Holst JJ, Nauck MA.

    Diabetes. 2005 Jul;54(7):2212-8.PMID: 15983224 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Postprandial hormone and metabolic responses in simulated shift work.

    Hampton SM, Morgan LM, Lawrence N, Anastasiadou T, Norris F, Deacon S, Ribeiro D, Arendt J.

    J Endocrinol. 1996 Nov;151(2):259-67.PMID: 8958786 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.

    Thomsen C, Storm H, Holst JJ, Hermansen K.

    Am J Clin Nutr. 2003 Mar;77(3):605-11.PMID: 12600850 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity